These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 27032502

  • 1. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS, Seo SW, Sunwoo SY, Yoo SJ, Kim MH, Lyoo YS.
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [Abstract] [Full Text] [Related]

  • 2. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
    Jeong J, Park C, Oh T, Park KH, Yang S, Kang I, Park SJ, Chae C.
    Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
    [Abstract] [Full Text] [Related]

  • 3. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF, Van Breedam W, De Jong E, Lopez Rodriguez A, Karniychuk UU, Vanhee M, Van Doorsselaere J, Maes D, Nauwynck HJ.
    Vet Microbiol; 2013 Dec 27; 167(3-4):260-71. PubMed ID: 24041768
    [Abstract] [Full Text] [Related]

  • 4. An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
    Fontanella E, Ma Z, Zhang Y, de Castro AM, Shen H, Halbur PG, Opriessnig T.
    Vaccine; 2017 Jan 03; 35(1):125-131. PubMed ID: 27876202
    [Abstract] [Full Text] [Related]

  • 5. Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus.
    Pujhari S, Baig TT, Hansra S, Zakhartchouk AN.
    Virus Res; 2013 May 03; 173(2):321-6. PubMed ID: 23353778
    [Abstract] [Full Text] [Related]

  • 6. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J, Kang I, Kim S, Park SJ, Park KH, Oh T, Yang S, Chae C.
    Transbound Emerg Dis; 2018 Oct 03; 65(5):1227-1234. PubMed ID: 29536637
    [Abstract] [Full Text] [Related]

  • 7. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM, Ni YY, Cao D, Tian D, Yugo DM, Heffron CL, Overend C, Subramaniam S, Rogers AJ, Catanzaro N, LeRoith T, Roberts PC, Meng XJ.
    J Virol; 2018 Jul 01; 92(13):. PubMed ID: 29643245
    [Abstract] [Full Text] [Related]

  • 8. Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.
    Renson P, Fablet C, Andraud M, Normand V, Lebret A, Paboeuf F, Rose N, Bourry O.
    Vaccine; 2019 Jul 18; 37(31):4318-4324. PubMed ID: 31248683
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P, Gozio S, Ferrari L, Rosina S, De Angelis E, Quintavalla C, Bottarelli E, Borghetti P.
    Vaccine; 2009 Jun 08; 27(28):3788-99. PubMed ID: 19442420
    [Abstract] [Full Text] [Related]

  • 10. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D, Gerber PF, Xiao CT, Halbur PG, Wang C, Tian D, Ni YY, Meng XJ, Opriessnig T.
    Vaccine; 2016 Nov 04; 34(46):5546-5553. PubMed ID: 27742217
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena.
    Trus I, Bonckaert C, van der Meulen K, Nauwynck HJ.
    Vaccine; 2014 May 23; 32(25):2995-3003. PubMed ID: 24709589
    [Abstract] [Full Text] [Related]

  • 12. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
    Park C, Choi K, Jeong J, Chae C.
    Vet Microbiol; 2015 May 15; 177(1-2):87-94. PubMed ID: 25769646
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
    Geldhof MF, Vanhee M, Van Breedam W, Van Doorsselaere J, Karniychuk UU, Nauwynck HJ.
    BMC Vet Res; 2012 Oct 03; 8():182. PubMed ID: 23031319
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS, Kvisgaard LK, Pawlowski M, Holmgaard Carlsen S, Hjulsager CK, Heegaard PMH, Bøtner A, Stadejek T, Haugegaard S, Larsen LE.
    Vaccine; 2018 Jan 04; 36(2):227-236. PubMed ID: 29191738
    [Abstract] [Full Text] [Related]

  • 16. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P, Cordioli P, Alborali LG, Gozio S, De Angelis E, Ferrari L, Lombardi G, Borghetti P.
    Vaccine; 2007 Apr 30; 25(17):3400-8. PubMed ID: 17276558
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain.
    Sattler T, Pikalo J, Wodak E, Revilla-Fernández S, Steinrigl A, Bagó Z, Entenfellner F, Claude JB, Pez F, Francillette M, Schmoll F.
    BMC Vet Res; 2018 Apr 19; 14(1):133. PubMed ID: 29673363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W, Platt R, Johnson W, Roof M, Vaughn E, Roth JA.
    Vet Immunol Immunopathol; 2006 Jan 15; 109(1-2):99-115. PubMed ID: 16165219
    [Abstract] [Full Text] [Related]

  • 20. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
    Ferrari L, Martelli P, Saleri R, De Angelis E, Cavalli V, Bresaola M, Benetti M, Borghetti P.
    Vet Immunol Immunopathol; 2013 Feb 15; 151(3-4):193-206. PubMed ID: 23228653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.